{"id":"W4394823979","doi":"10.1097/ju9.0000000000000138","title":"Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2","year":2024,"lang":"en","type":"article","venue":"JU Open Plus","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Janssen Biotech; Foundation Medicine; National Cancer Institute; Cancer Center, University of Colorado; National Institutes of Health; Astellas Pharma; Daiichi-Sankyo; Invitae; National Center for Advancing Translational Sciences; Seagen; UroGen Pharma; Clovis Oncology; Sanofi; Exelixis; Advanced Accelerator Applications; Regeneron Pharmaceuticals; Prostate Cancer Foundation; Bristol-Myers Squibb; AstraZeneca; Myriad Genetics; Celgene; Amgen; Pfizer","keywords":"Prostate cancer; Medicine; Narrative review; Narrative; Oncology; Cancer; Management of prostate cancer; Gynecology; Internal medicine; Intensive care medicine; Art","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003085433,0.0001905329,0.000475063,0.00007585935,0.0001223119,0.0001116261,0.000144059,0.00002329949,0.0002239553],"category_scores_gemma":[0.00005800281,0.0001101197,0.00005790027,0.0003564174,0.0002318597,0.000180273,0.0001344293,0.0001818074,0.000002557313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004801576,"about_ca_system_score_gemma":0.0006995183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003187998,"about_ca_topic_score_gemma":0.002902539,"domain_scores_codex":[0.9985448,0.00007027631,0.0003558747,0.0004538815,0.0003302064,0.0002450163],"domain_scores_gemma":[0.9992768,0.0000763559,0.0001249939,0.0002823597,0.0001724487,0.00006705749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01887277,0.001793407,0.02899099,0.05778612,0.01070715,0.01824038,0.5424325,0.0003264085,0.003531968,0.01566296,0.2689369,0.03271843],"study_design_scores_gemma":[0.0253718,0.002734448,0.07750041,0.11835,0.003275525,0.0003357769,0.1517852,0.0009169281,0.00765076,0.0008125628,0.6097236,0.001543015],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.351503,0.4785458,0.000001510042,0.1295839,0.0005338547,0.01756144,0.0006277679,0.00004528154,0.02159757],"genre_scores_gemma":[0.8119681,0.1553962,0.00005150171,0.0008255027,0.0000319457,0.002405237,0.00002529371,0.00002396499,0.02927216],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.4604652,"threshold_uncertainty_score":0.4819321,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05177091720800439,"score_gpt":0.3919593903076974,"score_spread":0.340188473099693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}